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Thecarcinogenicity database usedforthispaperoriginatedinthelate 1960sbythe National CancerInstitute(NCO)and
since 1978hasbeencontinuedandmademorecomprehensivebytheNationalToxicologyProgram(NTP). Theextensive
filescontain,amongothersetsofinformation, detailedpathologydataonmorethan400long-term(mostoften24-month)
chemicalcarcinogenesisstudies, comprisingnearly 1600individualexperimentshavingatleast 10milliontissuesections
that have beenevaluated fortoxicity andcarcinogenicity. Usingthis datasetwehavea)deternmned theconcordance in
carcinogenicresponses betweenratsandmicetobe74%andbetweensexestobe85% (rats)to87% (mice);b)discovered
that using male rats and female mice would have identified correctly 95% ofthe positive or noevidencechemical car-
cinogenicity resultsobtainedusingthemoreextensiveprotocol; c)establishedahistoricalcontrolfileoftumorincidence
data; d) evaluated thefalsepositiverateintheinterpretation ofcarcinogenesisstudies, concluding thatthis rateispro-
bably nomorethan7to8%; e)compiledlistngsofchemicalshavinglikecarcinogenictargetsitesforeachofthe37organs
orsystemsforwhichhistopathoo diag shavebeenrecordedroutinely;J) demonstratedthatevaluationofsite-specific
carcinogenic effectsarepreferable todoinganalysesbasedonoverall(allsitescombined) tumorrates;g)learnedthatfew
chemicalscauseonly benign tumorsoronly livertumors, themostcommontargetsiteforchemically inducedcancers;
h)identifiedkeysourcesofvariability intunorratesinlong-termcarcinogenesisstudies;i)asertainedthatcornoilgavage
orgavageperseexhibitslittle, ifany,adverseimpactonlong-termstudies;J)showedthattheSalmonellamultistrainassay
wasasgoodasabatteryoffourshort-termin vitrotestsforpredictingin vivocarcinogenicity, yetwasonly66% concor-
dantwithan89% positivepredictvityanda55%negativepredictivity;k)iN i thereationshipbetweenchemically
inducedtoxicity andchemicaly associatedcarcinogenicity, findingthatfewchemicalscausetumorsonlyatthehighest
exposureconcentration. These (andother)derivedcompilationsaremostuseful formaintainingahistoricandobjective
perspectivewhenevaluatingthecarcinogenicity ofcontemporaryexperimentsandforidentifyingpotentialcarcinogenic
hazards to humans.
Introduction
Sincetheintroductionofexposinganimals tochemicals in 1918
by Yamagiwa and Ichikawa for detecting chemical carcinogens
(1,2), much has been learned about the relevance ofthese fin-
dings for possible effects in humans. Likewise, an enormous
amountofknowledgehasbeen gained overthe years onhow to
design, conduct, monitor, evaluate, and interpret the data col-
lected from these carcinogenesis studies (3-7). Evaluating
chemicals inlaboratory rodents as surrogates forpotentialhuman
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health hazards remains the cornerstone for identifying those
chemicals mostlikely to cause cancerin humans (8-14).
Otherthanhumanexperienceandepidemiological investiga-
tions, long-term studies in laboratory animals are the most
validated and universally accepted means to determine car-
cinogenic hazards to thepublic health and to the environment
(e.g.,5,6,8-22). Themajorpublichealthattributeoftheselong-
termchemicalcarcinogenesisexperiments istoallowbetterrisk
assessment(5,9,10) andriskmanagementdecisions(23,24) tobe
madeforreducing, preventing, oreliminating exposurestothose
chemicalsidentifiedasconstitutingrealriskstohumans(25-27).
Thefindingsfromtheselong-termstudies assumeamajorrole
inthekey firststepintheriskassessment-risk managementpro-
cess and a contributory part in the second step ofthe process
(9,23,24) (Table 1).HUFFAND HASEMAN
National Research Council/National
Academy ofSciences, 1983 (23)
Hazard identification: determination
ofwhether aparticular chemical is
or is not causally linked to par-
ticular (adverse) health effects.
Dose-response assessment: deter-
mination ofthe relation between
the magnitudeofexposure andthe
probability ofoccurrence ofthe
(adverse) health effects inquestion.
Exposure assessment: determination
ofthe extent ofhuman exposure
before orafterapplication of
regulatory controls.
Riskcharacterization: description of
the nature andoften the magnitude
ofhuman risk, including attendant
uncertainty.
Task Force on Health Risk
Assessment, 1986 (24)
Hazard identification: qualitative in-
dicationthat asubstance/condition
may adversely affect human
health.
Hazard characterization: qualitative
andquantitative evaluation ofthe
nature ofthe adverse effects, inclu-
ding theirexpression as functions
ofthe amount ofexposure (dose).
Exposurecharacterization:
qualitative and quantitative evalua-
tionofthedegree ofhuman ex-
posure likely to occur.
Riskdetermination: integration of
these steps into a scientific deter-
mination ofthe level ofrisk as a
basis forpolicy consideration.
As illustrative andimportantexamplesofpreventivemedicine,
the International Agency for Research on Cancer (25,28,29)
periodically re-evaluates all those chemicals or agents having
availablehumandata, andthese consensus findingsandrationale
arepublishedinsupplementsthatcontaingroupingsofchemicals
andagentsconsidered tobecarcinogenic, probablycarcinogenic,
orpossibly carcinogenic tohumans, along withthosechemicals
not classifiable or probably not carcinogenic to humans (25).
Similarly, and as mandated by the U.S. Congress, the Depart-
mentofHealthandHumanServicesviatheU.S. NationalTox-
icology Program (NTP)evaluatestheavailabledataandplaces
chemicalsinto oneoftwocategories: knownhumancarcinogens
andthosereasonablyanticipated tobehumancarcinogens(27).
Oncethese areidentifiedbyeitheroftheseorganizations, other
state, national, andinternational agencies, aswell aspublicand
privateinterest groups, assessthepossibleadversehealthimpact
these agents mayhave onexposed persons. Variousactions may
be taken to reduce or eliminate exposures to the identified
hazard, tolocateandstudyrelevanthumancohortsforpossible
carcinogenicity, and to attempt further studies to better
characterizetheidentifiedpotentialrisktohumans(8,10,12,13).
Inthemiddle 1960sandearly 1970s, the National CancerIn-
stitute (NCI) initiated an extensive carcinogenesis bioassay
screening program and published in 1976 the first of 200
technical reports (30,31). TheNTPcontinues theseefforts, and
about250 moretechnical reportshavebeenissued or areinpress
(11,32). Thesedataandvarious subcombinations formthebases
for this overview paper. Parts ofthis overview come from our
previously reportedandpublishedanalysesandinterpretations.
For readers wanting more details and perhaps larger bibliog-
raphies, please consult the references given at the end ofthis
paper. Mostofthepapersauthoredby us ortheindividualprinted
technical reports on the chemical carcinogenesis studies are
available upon written request.
Theoverriding aim fordoing these individual andcollective
analyses comes fromthenever-ending need to morecomplete-
ly understand the fundamental biological principle that ex-
trapolationofexperimental andepidemiologicalfindingsamong
themammaliankingdomissoundscience. Theulfimatevalueof
these data and resultant interpretations will continue to allow
more knowledgeable public, occupational, and environmental
health decisions.
Materials and Methods
The chemical carcinogenesis data given in this paper come
fromtheNCIandNTPTechnicalReportsSeries, whichdescribe
theresultsoflong-termstudies inrodents(11,32). Comparedto
others who compile information about carcinogenicity of
chemicals, ourprogramisuniqueinthat wedesign,conduct, and
evaluate our ownexperiments, whereasotherstypicallyrecord
the results and conclusions made by the various investigators
reporting theirdata intheliterature. Further, and most impor-
tandy, ourdataand interpretations arepeer-reviewed inpublic
sessionsbeforethetechnicalreports are finalize andmadeready
forprintinganddistribution. Intotal, thedatabaseusedforthis
papercomprises 379long-termchemicalcarcinogenesis studies
involving 1394 individual experiments: male rats, female rats,
malemice, andfemale mice (5,10).
Thesetoxicology studies aretypicallycarriedoutusingboth
sexesoftwospeciesofrodentsdividedrandomlyinto setsof50
to 60 animals per group; a control group and two or three ex-
posure concentrations are graduated down from a carefully
selected toplevel(3,5,6,11,19,33-35). Thespecies mostoften us-
ed by the NTP are the inbred Fischer 344 rat and the hybrid
B6C3F, (C3H x C57B16) mouse. Duration of exposure is
generally 2 years (or about 2/3 the life span of these rodent
species). Thedata, results, evaluations, andinterpretations are
peerreviewedinpublicmeetings,andthischemical-specific in-
formationismadeavailableintheNTPTechnicalReportsSeries
(11)
Resultsand InterpretativeObservations
Long-Term Chemical Carcinogenesis Studies
A continuing evaluation ofthe NCI/NTP database oflong-
termchemicalcarcinogenesis studieshasresultedin anumber
ofusefulscientificfindings, severalofwhich aresummarizedin
this section. Nearly 450 chemical-specific studies have been
reported, mostoften involving groups ofmale and female rats
andmiceexposedto achemicalfor2 years(11,30-32,36,37). The
collated findings are evaluated, interpreted, and presented in
publicmeetings to anongovemmentpeerreviewpanelofexperts
inchemical carcinogenesis.
Each sex-species experimental grouping is given an overall
levelofevidenceofcarcinogenicityselectedfromfivecategories:
two positive levels (clear evidence and some evidence), one
uncertain but not negative (equivocal evidence), one for no
observed response (noevidence), and oneforseriously flawed
experiments (inadequateexperiment) (38-41).
Roughly one-half of the chemicals induced a positive car-
cinogenic response in at least one ofthe several experiments
(Table 2). Only 43 ofthe 313 chemicals (13.7%) studied ade-
quately in male and female rats and in male and female mice
caused cancer in all fourexperimental groups, and 25 (8.0%)
produced cancer in one or more sites in three ofthe four ex-
periments (Table 3). These findings will generally cause a
chemical to be placed into the sufficient evidence of car-
cinogenicity category (25,26) and into the groupofsubstances
reasonablyanticipatedtobecarcinogens(27). Aprimevalueof
theseresultspermitsidentificationofthosechemicalsconsidered
Table 1. Risk assessment: comparative definitions.
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Table2. Sumnary resultsfrom379carcinogenicity studiesinrodents (49).
Study
result
Positive
Equivocal
No evidence
Totals
By experiment
Male Female Male Female
rats rats mice mice Total
127 107 102 123 459
41 36 35 20 132
183 211 204 205 803
351 354 341 348 1394
By chemical
Rats Mice Overall
146 137 198
48 35 53
162 178 128
356 350 379
Table 3. Carcinogenicity results for 313 chemical studies in rodents (49).'
Proportion
ofpositive Male Female Male Female Numberofstudies
studies rats rats mice mice with these results %
4/4 + + + + 43
Subtotals 43 13.7
3/4 + + + -
+ + - + 11
+ - + + 7
- + + + 6
Subtotals 25 8.0
2/4 + + - - 19
+ - + - 2
+ - - + 7
- + + - 2
_ + - + 3
- - + + 23
Subtotals 56 17.9
1/4 + - - - 17
- + - - 4
- _ + - 9
- _ - + 8
Subtotals 38 12.1
0/4 - _ - - 151
Subtotals 151 48.2
Totals 313 100
aIncludes only those long-term studies considered adequate in all four sex-
species experiments. Equivocal evidence (ormarginal) results areconsidered
to be between apositive response and no evidenceofa response; these results
wereplaced intothe no evidence category.
most likely to be potentially carcinogenic to humans, and thus
epidemiological investigationshavingadequatecohortscouldbe
initiated. As an example, the carcinogenicity of 1,3-butadiene
was first determined in animals, and a subsequent epidemio-
logicalinvestigationrevealedapositiveassociationbetweenex-
posure and cancers (8).
Species Correlations
In these studies, similar results areobserved inboth species
74% ofthe time, and the concordance between sexes within a
species rangesfrom85% (rats) to87% (mice) (Table4) (42). To
maintaintheimportantcontributionofhormonalinfluenceonthe
carcinogenesis process, weconductedaretrospectiveevaluation
onthisquestion: Forhowmanyoftheoutcomeswould wehave
foundthe same (asimplequalitativeyes[+I orno[-]) resultif
wehadusedareducedprotocolofonlyone-halftheexperimental
groups? Using male rats and femalemice, the answer was that
96% ofthechemicals wouldhavebeencorrectlymatchedtothe
positive or negative result ofthe more extended experimental
protocol (10). Importantlyhowever, 13chemicalscausing single
sex-speciespositives ineitherfemalerats(four) orinmalemice
(nine) would have been missed, as would 2 chemicals causing
carcinogenic effects inbothfemale ratsandinmalemice(Table
Table4. Intra-andintespeciesconcordance incarcinogenicresponsesin379
chemicalcarcinogenicity studies in rodents (49).a
% Concordant
Observed response (+/+ or-/-)
Comparison +/+ +/- -/+ -/- responses
Male rats vs. female rats 88 38 16 207 84.5 (295/349)
Male rats vs. malemice 54 54 40 169 70.3 (223/317)
Maleratsvs. female mice 70 41 41 169 74.5 (239/321)
Femalerats vs. malemice 53 38 42 185 74.8 (238/318)
Female rats vs. female mice 65 28 47 183 76.8 (248/323)
Male micevs. femalemice 88 14 31 206 86.7 (294/339)
Ratsvs. mice 82 40 40 151 74.4 (233/313)
aEquivocal evidence (or marginal) results are considered to be between a
positiveresponseandnoevidenceofaresponse; theseresults wereplaced into
the no evidencecategory.
3). Forall 15chemicallyassociatedresponses, there wereonly
single target organs per sex-species (not considering here
equivocal responses), andforonly onechemical was thetarget
site sex-specific (uterus).
Themajorquestionsthatarisefromthisretrospectiveevalua-
tioncenteronwhetherusingthismodifiedprotocalinthefuture
onthenextgroupof400equallydiversechemicals woulda)per-
mitthesamepercentageofcorrectresponsesandb)allowusnot
tomissanypotentialcarcinogenichazardstohumans. Whilewe
contemplateanswerstothesequestions, perhapsonecouldcon-
siderusingamodifiedprotocolforcertainstructuralcertainties;
that is, ifanorganization had to study a certainnitrosamine, a
benzidineoranthraquinonedye, orananilinecompound, forex-
ample, then a modified protocol could be possible. For "un-
known" chemicals, one would be wise to remain with the
historically andcurrently acceptableparadigmofboth sexesof
two rodent species.
Historical Control TumorData
Althoughwhenevaluatinglong-termchemicalcarcinogenesis
experiments, themostappropriatecontrolgroupforcomparative
and interpretative purposes is always the concurrent control,
thereareinstances inwhichtheuseofhistorical controlinforma-
tioncanaidaninvestigatorintheoverallevaluationoftumorin-
cidence data. One example is for rare (oruncommonly occur-
ring)tumors; anotherisforatumortypethatshowsamarginally
significant chemically related increase relative to concurrent
controls.
TheNTPhistoricalcontroltumordatafileisa"movingwin-
dow" ofstudies conducted within approximately a 4 to 5 year
timeperiod, anditisupdatedapproximatelytwiceayear. Thus,
as new data are entered, the oldest data are removed (but of
course not discarded). Periodically, control tumor rates are
published for informational purposes (43-45).
The extensive NTP database is an important and frequently
used sourceofinformation onhistorical controltumors, andin
somerespectsdiffersfromothers inthata)typicallythetumor
diagnoses and therefore incidence data have been verified by
comprehensive quality assurance and pathology review pro-
cedures, b) tumordiagnostic nomenclature andcriteria across
experiments and laboratories are consistent, and c) these data
come from one source (albeit several laboratories conductthe
studies and record the initial tumordiagnoses), whereas other
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availabletumordatabasesoftencomefrommyriadlocations. In
eachNTP TechnicalReport, therelevanthistoricalcontroltumor
incidence data are given for all tumors showing possible
chemically relatedeffects. Mostimportantarerelatively recent
studies carried out at the particular study laboratory. In-
vestigators fromindustry andothergovernmentalagenciesalso
frequently requestuseofthehistorical controldatabase sothat
they canbetterinterpretandcomparethebackgroundtumordata
oftheirown studies.
FalsePositive and FalseNegative Rates
In long-term chemical carcinogenesis studies, approximate-
ly30to40differenttissuesororgansareexaminedforpossible
carcinogenic effects in male and female rats and mice. Under
theseconditions itisnotunusualtofindstatistically significant
changesintumorincidencethatmerelyreflectrandomvariabili-
ty. Ourdatabase provides auniqueopportunity toexaminethe
pattern andfrequency ofsite-specific tumorincidences, andto
estimatethelikelihoodoffinding statisticaldifferencesbychance
alone.
Forexample, Haseman(46) examinedthe falsepositive rate
inNTPstudiesbyderivingastatisticaldecisionrulethatclose-
ly approximated thecomplexscientificjudgmentprocess used
in the evaluation of these studies. This "rule" (useful as a
guideline, butshouldnotbeappliedrigidly) istodeclareanin-
crease in the incidence in a commonly occurring tumor to be
biologically significantiftheuppermostexposurelevelincidence
compared to controls is significantly different at thep < 0.01
level. For an uncommonly occurring tumor (background rate
less than 1 or 2%), ap < 0.05 increase is typically required.
Fromthisevaluation, thefalsepositiverateassociatedwiththis
decisionrulewasdemonstratedtobenomorethan7to8%, im-
plying thatthe false positive rate in NTP studies is reasonably
well controlled. Coupledwithbiological significance, possible
mechanistic relevance, an overall historical perspective, and
public peer review, we believe that false positives results have
beenminimizedinourprogram. Amoredifficultpublichealth
issue that has rarely been considered is the false negative rate
within these relatively insensitive assays. Perhaps this will
receive moreattention inthe future.
The NTP database is also quite valuable for the study of
statistical decision rules, particularly those that require
knowledgeoftheincidenceandvariability ofhistorical control
data. Althoughsuchrulesshouldnotberigidlyapplied, asnoted
above, thesestatistical methodsmaybeusefulinthattheyemploy
a formal multiple comparisons adjustment to limit the overall
falsepositiverate. Foradiscussion ofstatisticaldecisionrules
that might be used in the evaluation oflaboratory animal car-
cinogenicity studies, seeHaseman (47).
Whileattention isoftenfocusedprimarily oncontrollingfalse
positive rates, one must rememberthatrodentcarcinogenicity
studieswithonly50to60animalspergrouparerelativelyinsen-
sitive for detecting weak to moderate carcinogenic responses.
Thus, thisinsensitivity mustalsobeconsideredwhendeciding
how toguardagainst falsenegative outcomes. Forexample, as
mentionedbelow, wedemonstratedthatanalysesbasedonoverall
(all sitescombined) ratherthansite-specific tumorrateswould
haveresultedinamarkedincreaseinthefalsenegativerate. That
is, several chemicals showing positive results evaluated using
site-specific comparisonswouldnothavebeenidentifiedusing
total numbers oftumor-bearing animals (48). Thus, the inter-
pretativeemphasisshouldcontinuetobeonsite-specificeffects.
Site-Specific Neoplasia
Using the NCI/NTP data set we have compiled listings of
chemicalshavinglikecarcinogenictargetsitesforeachofthe34
organsorsystemsforwhichhistopathologydiagnoseshavebeen
recordedroutinely(49). Themostcommontumorsiteistheliver
(15% ofall experiments) (50), followed in rankorderby lung;
hematopoietic system and kidneys; mammary glands; fore-
stomach; thyroidglands; Zymbalglands; urinarybladder; and
skin and uterus (Table 5) (49). These compilations are most
usefulformaintainingahistoricperspectivewhenevaluatingthe
carcinogenicityofcontemporary experiments. Equally impor-
tant, thechemical-tumor-organconnectionpermitsanevalua-
tionofhowwellchemicallyinducedcancersinaparticularorgan
inonesexorspecieswillpredictorcorrelatewiththeothersex
or species. Using liver cancers as an example,the overall in-
terspeciesconcordance is 80%. Likewise, target-sitepredictions
canbemadeforchemicalsselectedforstudythatmaybesimilar
tothosealreadyevaluated;therebyexperimentalprotocolscould
be adjusted to allow for example more extensive pathology on
preselectedtargetorgans(i.e., serialsectionsofthekidney). Fur-
therfromtheseobservations, onecoulddecidetousetwostrains
ofmicetoevaluateashort-chainchlorinatedaliphaticcompound
or to study a human carcinogen in a sex-species known to
developchemicallyinducedtumorsinthesamesiteobservedin
humans. Structuralclassesofchemicalshavingapropensityfor
certain organs can be easily identified from these data. Sex-
species responders to particular chemically induced cancers,
such as thekidney in malerats, can berecognizedataglance.
Likehumans, thetop 10sitesofcanceraresomewhatdifferent
between the sexes ofrodents. Yet when compared among the
mammalian speciesingeneral (includinghumans), thesitesand
rankings areremarkably similar (10,12,20,49).
Site-Specific versusTotal Tumors
Usingasubsetof81 carcinogenicity studies, weevaluatedthe
issueofinterpretingthetumorincidenceresultsbasedonthepro-
portionofanimalswithprimarytumors (allsites)orthepropor-
tionofanimals withmalignantneoplasms (all sites) compared
toanalysesofsite-specific carcinogenic effects (48). Lessthan
half of the 45 chemicals considered to have induced a car-
cinogenic responseinatleastonesiteinonesex-speciesexperi-
mentshowedasignificantincreaseintheincidenceofprimary
tumorscombined(22chemicals)ormalignanttumorscombin-
ed (21 chemicals). Among the29 chemicals interpreted as not
carcinogenicbasedonsite-specific effects, twoshowedsignifi-
cantincreases inoverall tumorincidence. Thus, consideration
ofoveralltumorsratesseeminglymaskedseveralimportantsite-
specificeffects, whileidentifying onlytwoadditionalchemicals
apparently missedbyusing site-specific analyses. These latter
two "carcinogenic responses" were not considered to be bio-
logically relevant (48).
Inouropinion,atleasttwomajorproblemsareassociatedwith
anevaluationbasedonoverall(allsites)tumorrates: combining
tumor types of varying morphologies and topographies is
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Table5.Organs/systemsmostfrequentlyobservedinratsandnicewithchemicallyinducedsite-specificcarcinogeniceffectsfrom379long-termchemical
carcinogenesisstudies (49).
Rats Mice Rats and mice
No. positive No. positive No. positive
Site studies Site studies Site studies
1. Liver 44 Liver 86 Liver 104
2. Kidney 28 Lung 23 Lung 30
3. Mammary glands 22 Forestomach 17 Hematopoietic system 29
4. Zymbal glands 18 Hematopoietic system 15 Kidney 29
5. Thyroid glands 17 Circulatory system 11 Mammary glands 27
6. Hematopoietic system 17 Thyroid glands 9 Forestomach 23
7. Forestomach 15 Mammary glands 9 Thyroid glands 19
8. Skin 15 Ovary 8 Zymbal glands 18
9. Urinary bladder 14 Harderian glands 7 Urinary bladder 16
10. Clitoral glands 10 Uterus 7 Uterus or skin 15
biologically unsound andscientifically questionable, andpool-
ing various tumor types reduces study sensitivity fordetecting
chemically related increases in site-specific tumorincidences.
Further, mostnationalandinternational guidelinesforstudying
chemicals for carcinogenicity in rodents (or in humans) em-
phasizesite-specific effects (6). Thus, despitepurportedadvan-
tagesofanalysesbasedonoverall tumorrates (e.g., simplicity;
reducing occurrenceoffilsepositiveandperhapsfalsenegative
results), primary emphasis shouldcontinuetobeplacedonsite-
specific analyses.
Benign Tumors
The importance and relevance ofbenign neoplasia in evalu-
atingthecarcinogenic potential ofaparticularchemical remains
anareaofactivediscussion, eventhoughfewifanychemicalson-
lycausebenignneoplasia. Toexplorethisissueweevaluatedthe
long-termcarcinogenesis results forthe 143 chemicalsreported
by the NTP: 81 ofthese showed neoplastic responses in one or
more of the 524 sex-species experiments (51). Of these 81
positive studies, 60 (74%) were considered positive based on
malignant neoplasia; 16 (20%) were positive dueprimarily to
benign neoplasia, but had supporting evidence of malignant
neoplasia in the same organ/tissue; and 5 (6%) were positive
basedonbenignneoplasiaalone. Ofthe200chemicalsevaluated
by NCI, only 2 were considered tobepositive basedprimarily
on benign tumors.
Thus, only 5 ofthe 143 chemicals evaluated induced benign
neoplasia alone (3.5%), andthose observed benign neoplasms
are known toprogress tomalignancy (51,52). Accordingly, we
consider chemically inducedbenignneoplasia tobe animpor-
tantindicatorofachemical's carcinogenicpotential inrodents,
andbelievetheseshouldcontinuetobemadeanintegralpartof
theoverall weight-of-the-evidence evaluationprocess foriden-
tifying potential human health hazards.
Sources ofVariability
Amajoradvantageofanextensivehistorical controldatabase
isthatitallows anexamination oftrendsintumorincidence (and
other potentially changeable biological parameters) over time
and within and between laboratories, thereby permitting the
identificationofimportant sources ofvariability. This informa-
tionisusefulinthedesignoflong-termchemical carcinogenesis
studies and may allow the investigator to address what would
otherwisebeconfoundingfactorsintheevaluationandinterpreta-
tionofthedata.Potentialsourcesofvariabilityincludetheanimal
roomenvironment, longevity and survivalpatternsofanimals,
dietaryfactors, anddifferencesrelatedtopathology(4,53).
Forexample, welearnedthattheFischer 344 ratsused inour
programhaveshownasteadyincreaseinthebackgroundrateof
certaincommonlyoccurringneoplasms(e.g., leukemia, andfor
certain glandular organs such as pituitary, mammary, thyroid,
andadrenal glands), togetherwith adecreased survival and an
increasedbody weight (54). A review ofslides from early and
relatively recent studies identified possible reasons for these
shifts. (Everyslidefromeverystudyiskeptinasecurityarchives
thatallowsthesehistoricalcomparisonsandalsopermitsothers
toview slides toverify ourdiagnoses; foratleast 10yearsafter
astudyisreported, thetissuesandremainingorgansfromeach
animal are retained in case new slides are needed.) The
possibilities include a) changes in histopathology diagnostic
criteriaovertime, b) changesintheamountoftissueexamined,
c) intra- andinterlaboratory variability, andd)dietary factors;
i.e., the incidence ofcertain neoplasms (particularly endocrine
systemandmammaryglandtumors)areknowntobepositively
correlated withbody weight; differences inprotein content in-
fluence kidney lesions in the rat.
Asimilarinvestigation inB6C3FI mice(55)didnotrevealthe
same striking time-related changes as seen in rats. The only
notable change was an increased incidence ofpituitary gland
neoplasmsinfemalemiceinthemorerecentstudies, whichmay
have been associated with increases in the amount ofpituitary
gland tissue examined. Additional investigation revealed that
liver tumor incidence in mice (particularly in females) was
highly correlated with body weight (53). Another factor that
mighthaveinfluencedbodyweight(therebyperhapsindirectly
affecting liver tumor incidence) was aprogram change inpro-
tocolmadein 1984thatresultedinmicebeinghousedindividual-
ly rather than in groups (56).
Ourinvestigationofsourcesofvariabilitywilllikelyleadtocer-
tainothersuggestedchangesinexperimentalprotocolordesign.
For example, an alternative diet containing (among other
modifications)lessproteinandmorefiberisbeingstudiedandwill
probablybeadoptedinthenearfuture. Thisshouldimprovesur-
vival and reduce tumor rates by limiting the weight gain ofthe
animals, aswellasreducingtheamountandseverityofprotein-
associatedlesionsintherodentkidney. Wehavealsogainedabetter
understandingofthevalueandlimitationsofhistoricalcontroldata
intheoverallassessmentoftumorincidence(mentionedearlier).
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Routes ofExposure
Theoptimum routeofexposure forchemical carcinogenicity
experimentsshould beonethatmostclosely mimics themajor
humanexposureroute; thisisnotalwayspossible,buttheattempt
shouldbemade. Historically, chemicalshavebeenadministered
byasinglerouteofexposure: usuallyinthefeed(60% ofthetime
forthedatabaseofthenearly400studiesweevaluated), butalso
byoral intubation (27%), by inhalation (5%), by applicationto
theskin(3%), byintraperitoneal injection(3%), orindrinking
water(2%)(10). Intubation isgenerally usedforadministering
unstable, volatile, orreactivechemicals. Microencapsulation is
a newly developed technique foradministering these agents in
feed andwillgenerally beusedto replacethegavagetechnique
(57,58). Thisdatabasepermits anevaluationofthepossible ef-
fects ofrouteofadministration oncarcinogenic response.
Sinceoralgavagefrequently employscornoilasthevehicle,
aquestionofparticular interestwaswhetherornotcorn oilaf-
fectstumorincidence. Toanswerthequestion, acomparisonwas
madeoftumorratesinuntreated(orbasaldiet)controlsandcorn
oil gavage controls, taking into account any interlaboratory
variability and time-related trends. Haseman etal. (44) found
thatcornoilhas noapparenteffectontumorincidence inmale
and female B6C3F, miceorinfemaleF344 rats. Inmale F344
rats, however, cornoilwasassociatedwithadecreasedincidence
ofmononuclearcellleukemiafromapproximately27to 14% and
anincreased incidenceofacinarcelltumorsofthepancreasfrom
approximately 0.2 to4.4%. Thesechangesappeared relatedto
corn oil rather than to thegavagetechnique itselfbecause con-
trols from gavage studies using water as the vehicle showed a
tumorresponseforleukemiaandpancreaticacinarcelltumors
similar to that observed for untreated basal diet controls. In-
terestingly, acinarcelltumorsofthepancreas werenotaffected
uniformlybecausecontemporary controlsadministeredcornoil
fromtheidenticalbatchdidnotshowsimilarincreases. Further,
ifthetwocontrolgroupswiththelargestaveragebody weights
are removed from the analysis, the difference for pancreatic
tumors between basal and corn oil controls is no longer sta-
tistically significant.
A long-term study wasdesigned toevaluate the influence of
various levels ofcorn oilandofselectotheroils (sesame seed,
sunflowerseed, andtricaprylin) onthecarcinogenic potential in
F344 rats. Preliminary results strongly confirmbothofthe ef-
fectsnotedabove. Ourincreasedunderstandingoftheimpact(or
inmostcases, thelackofimpact)ofcornoilgavageontumorin-
cidenceincreasesourconfidence intheinterpretationofstudies
using corn oil as the vehicle (and gavage as the route of ad-
ministration). Theseresultsmayalsohaveimplicationsconcer-
ningpossibledietarychangestoincreasethesurvivalofF344rats
(leukemia isthe leadingcause ofdeath intheseanimals).
Predicting Carcinogenicity with Genetic
Toxicity Assays
Fourwidelyusedinvitrogenetictoxicityassaysmereevaluated
todeterminetheirindividualandcollectiveconcordancewiththe
carcinogenicity ofa number ofchemicals. The endpoints and
short-termassaysweremutagenesisinSalmonellatyphimurium
andinmouselymphomacellsandchromosomeaberrationsand
sisterchromatidexchanges inChinesehamsterovarycells. The
Table 6. Pattern ofshort-term in vitr test results and long-term in vivo
carcinogenesis reultsfor 114chemicals.
Short-term in vitrotestand results Rodentcarcinogenicity results
SAL ABS SCE MLA Positive Negative
4/4 + + + + 22 3
Subtotals 22 3
3/4 + + + - 0 0
+ + - + 2 0
+ - + + 4 1
- + + + 8 6
Subtotals 14 7
2/4 + + - - 0 0
+ - + - 0 0
+ - - + 2 0
- + + - 2 3
- + - + 0 0
- - + + 7 12
Subtotals 11 15
1/4 + - - - 2 0
- + _ 1
_ _ + 3 1
- - - + 3 6
Subtotals 9 8
0/4 - - - - 11 14
Subtotals 11 14
Totals 67 47
Abbreviations: SAL, Salmonella typhimurinum; ABS, chromosome aberra-
tions(CHOcells); SCE, sisterchromatidexchanges(CHOcells); MLA, mouse
lymphoma.
original investigation with73chemicals (59)hasbeenfollowed
up with an additional 41 chemicals (60-63).
Resultsfrombothstudiesweresimilarandaresummarized in
Table6forthecombined 114chemicals. Salmonellaperformed
bestamongthe four short-termtests, achieving a66% (75/114)
concordance, an89% (32/36)positivepredictivity, anda55%
(43/78) negativepredictivity ofcarcinogenicity. Chromosome
aberrationsalsoshowedasignificantassociationwithrodentcar-
cinogenicity, butnonewasobservedforthesisterchromatidex-
changeormouse lymphomaassays.
Althoughtheperformanceofindividual short-termtests was
ofinterest,theprimaryfocusoftheinvestigationwaswhetherthe
performance ofindividual short-term tests for predicting car-
cinogenicity couldbeimprovedbyusingabatteryoftwoormore
tests. Importantly, these data demonstrate, at least for these
assaysandforthisparticular 114chemicaldataset,thattherewas
noevidenceofcomplementarityamongthefourshort-term tests,
and no combination constructed from these assays improved
substantially theperformance over the Salmonella multistrain
assay alone.
These results led our program to adopt Salmonella as the
primary in vitroshort-termassay toidentifymutagens. Useofthe
threeothershort-termtestsnotedabovehasbeencurtailed. The
NTPisnowevaluatinginvivotestsforchromosomeaberrations
andmicronuclei as apossiblemeansofpredictingorconfirm-
ing in vitromutagenicity and in vivocarcinogenicity.
ChemicalToxicity andCarcinogenicity
The possible interrelationships between toxicity (histo-
pathologicalobservations), genotoxicity (i.e., Salmonella), and
chemicalcarcinogenicityinlaboratoryrodentswasinvestigated
usinginformationobtainedandreportedfrom2-yearstudiesin-
volving 99chemicals (64). Although targetorgantoxicity and
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carcinogenicityoccurredtogetherinsomestudies(particularly
forthenasalcavityandkidney),manychemicalsproducedcarcin-
ogeniceffectsinorgansshowingnoevidenceoftoxicity,andcon-
versely, toxicity was frequently observedinorgansshowingno
chemicallyrelatedcarcinogeniceffects. Thedatasuggestedthat
only7ofthe53chemicalscausingcancerinatleastoneorganof
onesexofonespeciesexhibitedthetypesoftargetorgantoxicity
thatmighthavebeenthecauseofalltheobservedcarcinogenic
effects.
Ofthe 127positive sex-species experiments thatusedmulti-
pledoses, 54(43%)produced statistically significantincreases
intumorincidenceonlyatthetopdose. However, in78% (42/54)
oftheseexperimentstheincidencesofsite-specifictumorsinthe
lower-dose groups were also numerically elevated relative to
controlsandwereconsideredtobebiologicallyrelevant. Thus,
only9% (12/127)ofthecarcinogenic effectsappearedtoreflect
a "high-doseonly" response. Moreover, noapparentdifference
inmutagenicityasmeasuredbytheSalmonellaassaywasobserv-
ed between high-dose only carcinogens and the entire set of
chemicalcarcinogens. Inasubsequentcorrelationalanalysesof
an additional 31 chemicals, the results substantiate those sum-
marized above (65,66).
Although cell proliferation and its possible impact on car-
cinogenicresponsewerenotassesseddirectly,theseresultsnever-
thelesssuggestthatonlyarelativelysmallpercentageofchemical
carcinogens canbe identified aspossibly actingthroughan in-
direct or secondary mechanism. Thus, any attempt todevelop
genericregulatorypolicyforchemicalcarcinogensbasedsolely
ontheuseof2-yearrodentstudiestodifferentiatebetween"pri-
mary" and "secondary" carcinogens will likely be ineffective
and/or inaccurate unless specifically backed by relevant
mechanisticstudies (64).
Melnick (67) evaluated the available information on the in-
fluenceofcellproliferation(ormitogenesis)onthecarcinogenic
process in rodents. Although cell proliferation has long been
knowntohavearoleinchemicallyinducedtumordevelopment,
Melnick(67)concludedthatacorrespondencebetweensustained
cellularproliferationandcarcinogenicresponsehasnotbeende-
monstratedadequatelytosupportthehypothesisthatchemically
inducedcellproliferationcauseslivercancer. Further,theproli-
ferativeresponseresultingfromexposuretomany"nongenotoxic
"carcinogensisnotatallwellsustained,yettheelicitationofacar-
cinogenicresponsebythesechemicalsoftenrequiresaprolong-
edexposureduration.Thus,muchmoreresearchneedstobeac-
complishedbeforeanybasicaxiomsaboutthisimportantissuecan
beestablished(68).
DeductiveConclusions
Long-termchemicalcarcinogenesisstudiesmustbeproperly
designed, adequately conducted and monitored, subjected to
multi-tierpathologydiagnosesreview,andobjectivelyevaluated
and interpreted. In addition to having these essential scientific
characteristics, NTPstudiesundergoauniquepeerreviewpro-
cessthatisconductedinopenandpublicsessions.Inourview,this
makesthefindingsandresultsfromtheselong-termchemicalcar-
cinogenesisexperimentsevenmoreusefulandvaluableforiden-
tifyingpotentialcarcinogenichazardstopublichealth. Inaddition
toalertingustopossiblynewchemicalconcernsandsubstantiating
epidemiologicalobservations, thecollectivedataarevaluableand
usefulforamyriadofotherscientificpurposes. Somehavebeen
given in this paper. Others used or developed by us have been
publishedorareatvariousstagesofbeingpublished. Inoneman-
neroranothermostifnotallallowustobringfurtherknowledge
toandsupportforincreasingconfidenceinextrapolatingresults
fromanimalstohumans.Theknowledgeextendsfromtheclear
awareness that all ofthe chemicals known to induce cancer in
humansalsocausecancerinadequatelong-termanimalstudies
(8,10,12)totheincreasingawarenessthatoncogeneactivationpat-
ternsinhumanandanimaltumorsarestikinglysimilarandrepre-
sentevolutionaryconservation(e.g., 69-71).
Inouropinion, thedatafromthesestudiestogetherwith our
experienceovertheyearspermitustomakethefollowingcon-
clusions (notgiven inany particularorder):
1. Carcinogenicity findings from experiments in laboratory
animalsarelogicalandscientifically reasonableforiden-
tifying and predicting potential carcinogenic effects to
humans.
2. Mostchemicals arenotcarcinogenic.
3. Chemicals considered to be carcinogens may differ
significantlywithregardtothestrengthoftheinducedcar-
cinogenicresponse, andforpracticalpurposescanbedivid-
edintoqualitativegroupsbasedonempiricalindicatorsof
potency, i.e., exposureconcentrations, numberofpositive
experiments, multiplicityoftumorsites, numbersoftumors
per site, common versus uncommon tumors, site cor-
respondence across sexes and species, magnitude of in-
cidencerates, doseresponsepatterns, latency, metastases,
preneoplastic lesions (see Table 3 forexamples).
4. Malignantandbenigntumorsofthesamesiteand/ortype
shouldbecombinedforinterpretation. However, combin-
ingbiologicallyunrelatedtumorsforstatisticalevaluation
shouldbeavoided.
5. Benigntumorsinducedbychemicalsarerelevantforjudging
carcinogenicity; fewchemicalsproduceonlybenigntumors.
6. Site-specific tumoranalysesshouldbeusedfordetermin-
ingcarcinogenic effects.
7. Liver tumors are appropriate and valid for identifying
chemicalcarcinogensandfordeterminingpotentialcancer
hazards tohumans.
8. Cellulartoxicity andresultantsequelaearenotuniformly
associatedwithchemically inducedcarcinogenicity. Many
chemicalsproducecarcinogenicresponsesinorgansshow-
ing no evidence oftoxicity, and, conversely, toxicity fre-
quentlyoccurs inorgansexhibiting nochemically related
carcinogenic effects.
9. Mostchemicalcarcinogensdonotcausecanceronlyatthe
highestexposureused.
10. Mechanismsofactionarenotyetconsideredtobeunder-
stood well enough to become significant factors in the
evaluationsofchemicallyinducedcarcinogenesis, butcer-
ainlyallrelevantbiologicinformation(oncogeneactivation
and tumor suppressor genes, pharmacology and phar-
macokinetics, hormonalinfluences,andDNAdamageand
repair, amongothers)shouldbeconsideredwhendeciding
asinglelevel ofevidenceofcarcinogenicity.
11. Cellreplication(proliferation, mitogenesis)isanimportant
factorinchemicalcarcinogenesis, yetscientificdatadonot
sustainthehypothesisthatenhancedcellularproliferation
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in a particular organ associates consistently with an in-
creased induction ofneoplasia.
12. Therouteofexposurehaslittleornoeffectontheinherent
carcinogenicity ofachemical, althoughthespecificsitesof
carcinogenicity mayvarywiththerouteofadministration
used.
13. Corn oil has little or no influence on whether or not a
chemical is oris notacarcinogen.
14. Interspeciesconcordance incarcinogenicresponseisgood,
yetatleasttwospeciesshouldinmostcasescontinuetobe
used foridentifying chemical carcinogens.
15. Salmonellamutagenicityhasarelatively lowconcordance
with rodentcarcinogenicity.
16. Cagelocationandrelatedfactorshavenoimportantimpact
on chemical carcinogenicity.
17. Chemical structure in general does not allow for cancer
prediction in rodents orhumans.
18. Falsepositive rates associatedwithevaluatingchemically
induced carcinogenic effects in rodents are low. Unfor-
tunately, littleisknownaboutthefalsenegativerate, which
is ofmore importance topublichealth.
In conclusion, much has been learned from these largely
observational studies that permits us to make the above state-
ments, allofwhicharebasedonthedataandfactsgarneredfrom
theextensivechemicalcarcinogenesisdatabasedevelopedinse-
quencebytheNationalCancerInstituteandbytheNationalTox-
icology Program. This database is unique inthe sensethat not
only is it the single largest available collection of program-
generated chemical carcinogenesis facts and figures, but it is
perhaps theonly system containing carcinogenesis (andother)
data obtained from experiments that have been conducted and
evaluatedusingareasonablyconsistentcoreofdesignprotocols,
histopathological diagnostic criteria, and interpretational
guidelines (allofwhichhavebeenestablishedandhonedby us
over the years to keep reasonable pace with new and relevant
scientific advancements).
Another unique character of our data collection and com-
plementary pathology archives oftissue specimens and histo-
pathology slides is that we make the original data and slides
available to others to use in any way they wish. We also invite
individuals and organizations to study and scrutinize the raw
data and tissue specimens and sections that represent the ac-
tual experimentally generated information sources of the
database.
Staffconsistency and balanced scientific standards, together
with a public peer review process and a keen awareness ofthe
public health ethos must also be considered unique, desirable,
and supportive ofthe value ofthis particular data collection.
We thankanddedicatethispapertoDavidRall, whohasrecentlyretiredfrom
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tist. Weappreciate hisleadership, hispublichealthandenvironmentallyoriented
conscience, andhisbeliefandpracticethatgoodresearchcomesfromgoodscien-
tistswhonotonlymustbesupportedbutwhomustalsobeallowedtopursuetheir
research efforts unencumbered and with resolute freedom.
WealsothankJefFrenchandChris Portierforreviewingthismanuscriptand
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